[1]刘建平,廖火城,刘　凌,等.心包置管引流注入尿激酶和抗结核药物治疗结核性心包炎疗效观察[J].新乡医学院学报,2018,35(8):712-715.[doi:10.7683/xxyxyxb.2018.08.016]
　LIU Jian-ping,LIAO Huo-cheng,LIU Ling,et al.Clinical efficacy of pericardial catheter drainage injection of urokinase and antituberculous drugs in the treatment of tuberculous pericarditis[J].Journal of Xinxiang Medical University,2018,35(8):712-715.[doi:10.7683/xxyxyxb.2018.08.016]
点击复制

心包置管引流注入尿激酶和抗结核药物治疗结核性心包炎疗效观察
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
35
期数:
2018年8
页码:
712-715
栏目:
临床研究
出版日期:
2018-08-05

文章信息/Info

Title:
Clinical efficacy of pericardial catheter drainage injection of urokinase and antituberculous drugs in the treatment of tuberculous pericarditis
作者:
刘建平; 廖火城; 刘　凌; 钟思干; 肖　纯
（惠州市第三人民医院心内科，广东　惠州　516000）
Author(s):
LIU Jian-ping; LIAO Huo-cheng; LIU Ling; ZHONG Si-gan; XIAO Chun
（Department of Cardiology，the Third People′s Hospital of Huizhou City，Huizhou 516001，Guangdong Province，China）
关键词:
心包置管引流; 抗结核治疗; 尿激酶; 结核性心包炎
Keywords:
pericardial catheter drainage; antituberculous therapy; urokinase; tuberculous pericarditis
分类号:
R52；R542.1+1
DOI:
10.7683/xxyxyxb.2018.08.016
文献标志码:
A
摘要:
目的　探讨心包置管引流注入尿激酶和抗结核药物治疗结核性心包炎的临床疗效。方法　将惠州市第三人民医院2011年5月至2016年12月收治的132例结核性心包炎患者分为对照组和观察组，每组66例。全部患者均予以标准抗结核方案治疗，对照组患者在抗结核治疗的基础上予以传统心包穿刺术；观察组患者在对照组治疗的基础上给予心包置管注入尿激酶及抗结核药物治疗。比较治疗前后2组患者的心包积液量、心胸比（心影最大横径与胸廓最大横径之比）及治疗后的心包积液引流量和临床疗效。结果　治疗前2组患者心尖部、左心室后壁积液深度及心胸比比较差异无统计学意义（t=0.876、0.973、0.753，P>0.05）。治疗后，2组患者心尖部、左心室后壁积液深度、心胸比显著低于治疗前（对照组：t=9.572、10.727、3.257，P<0.01、P<0.05；观察组：t=15.322、16.962、4.662，P<0.01、0.05），且观察组患者心尖部、左心室后壁积液深度、心胸比显著低于对照组（t=5.322、3.836、3.611，P<0.05）。治疗后观察组患者心包积液引流量显著高于对照组（t=32.671，P<0.01）。对照组和观察组患者治疗总有效率分别为60.6%（40/66）和89.4%（59/66），观察组患者治疗总有效率显著高于对照组（χ2=14.591，P<0.01）。结论　心包置管引流注入尿激酶及抗结核药物治疗结核性心包炎对心包积液引流彻底，治疗过程中无明显并发症且临床疗效较好。
Abstract:
Objective　To evaluate the clinical efficacy of pericardial catheter drainage injection of urokinase and antituberculous drugs in the treatment of tuberculous pericarditis.Methods　One hundred and thirty-two patients with tuberculous pericarditis in the Third People′s Hospital of Huizhou City from May 2011 to December 2016 were selected.All the patients were divided into control group and observation group，with 66 cases in each group.All the patients were given standard anti-tuberculosis treatment，and the patients in the control group were given traditional pericardiocentesis on the basis of anti-tuberculosis treatment.While the patients in the observation group were treated with pericardial catheter infusion of urokinase and anti-tuberculosis drugs on the basis of treatment in the control group.The pericardial effusion volume and the cardiothoracic ratio were compared before and after treatment between the two groups.The drainage volume of pericardial effusion and the clinical efficacy were compared after the treatment.Results　There was no statistically significant difference in the pericardial effusion depth of apex of heart and left ventricular posterior wall and cardiothoracic ratio between the two groups before treatment （t=0.876，0.973，0.753；P>0.05）.After treatment，the pericardial effusion depth of apex and left ventricular posterior wall of heart and cardiothoracic ratio were significantly lower than those before treatment in the two groups （control group：t=9.572，10.727，3.257；P<0.01，P<0.05；observation group：t=15.322，16.962，4.662；P<0.01，P<0.05），and the pericardial effusion depth of apex and left ventricular posterior wall of heart and cardiothoracic ratio in the observation group were significantly lower than those in the control group （t=5.322，3.836，3.611，P<0.05）.After treatment，the drainage volume of pericardial effusion in the observation group was significantly higher than that in the control group （t=32.671，P<0.01）.The total effective rate of the patients in the control group and the observation group was 60.6% （40/66） and 89.4% （59/66），respectively.The total effective rate of the patients in the observation group was significantly higher than that in the control group （χ2=14.591，P<0.01）.Conclusion　The treatment of pericardial catheter drainage injection of urokinase and antituberculous drugs can drain the pericardial effusion completely，it has good clinical effect and no obvious complications.

参考文献/References:

［1］　曹仕鹏，傅满姣.40例结核性心包炎临床分析［J］.临床肺科杂志，2015，20（4）：586-588.
［2］　李杰，张芝辉，孔欣怡，等.T-SPOT.TB在结核性心包炎中的诊断价值［J］.实用医学杂志，2016，32（21）：3534-3536.
［3］　ZHENG X Z，TSAI Y T，LIN C Y，et al.Effusive tuberculous pericarditis［J］.Ann Thorac Surg，2017，104（5）：e397.
［4］　梁峰.结核性心包炎临床资料回顾性分析及研究［J/CD］.中西医结合心血管病电子杂志，2016，4（35）：138.DOI：10.3969/j.issn.2095-6681.2016.35.115.
［5］　LIEBENBERG J J，DOLD C J，OLIVIER L R.A prospective investigation into the effect of colchicine on tuberculous pericarditis［J］.Cardiovasc J Afr，2016，27（6）：350-355.
［6］　MUTYABA A，NTSEKHE M.The importance of perseverance，pilot studies and the search for effective adjuvant therapies in the management of tuberculous pericarditis［J］.Cardiovasc J Afr，2016，27（6）：336-337.
［7］　张伟，梅益斌，季乃军，等.T细胞斑点试验在结核性心包炎中的诊断价值［J］.中国乡村医药，2015，22（19）：66.
［8］　CHRISTIA P，MILES J，KATSA I，et al.Case of tuberculous pericarditis mimicking lupus carditis［J］.Am J Med，2017，130（11）：e475-e477.
［9］　LI H，LIU F Y，LI X L，et al.Clinical observation on pericardiocentesis and glucocorticoid in the treatment of tuberculous pericarditis［J］.Eur Rev Med Pharmacol Sci，2016，20（6）：1130-1134.
［10］　CHANG S A.Tuberculous and infectious pericarditis［J］.Cardiol Clin，2017，35（4）：615-622.
［11］　陆军，辛军，黎昱江，等.缩窄性心包炎32例的外科治疗［J］.岭南心血管病杂志，2015，21（4）：531-533.

更新日期/Last Update: 2018-08-05